NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated financial markets for 12,000 U.S. and global securities, today announced the fourth...
Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies for debilitating neurodegenerative disorders, today...
Alpha Cognition, Inc. (Nasdaq: ACOG) (“ACI” or the “Company”), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, and China Medical System...
Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies for debilitating neurodegenerative disorders, today...
Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies for debilitating neurodegenerative disorders, today...
Alpha Cognition Inc. (NASDAQ: ACOG) (“Alpha Cognition”, or the “Company”), announces that in connection with the Company’s listing on the Nasdaq Capital Market the Company will voluntarily delist...
Alpha Cognition Inc. (Nasdaq: ACOG) (CSE: ACOG) (“Alpha Cognition” [ACI], or the “Company”), a biopharmaceutical company developing novel therapies for debilitating neurodegenerative disorders...
Alpha Cognition Inc. (NASDAQ: ACOG) (CSE: ACOG) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.06 | 0.958466453674 | 6.26 | 7 | 5.8 | 203882 | 6.4703276 | CS |
4 | 0.33 | 5.50918196995 | 5.99 | 7 | 5.4 | 134607 | 6.11015728 | CS |
12 | -0.68 | -9.71428571429 | 7 | 7 | 4.66 | 123243 | 5.84958333 | CS |
26 | -0.68 | -9.71428571429 | 7 | 7 | 4.66 | 123243 | 5.84958333 | CS |
52 | -0.68 | -9.71428571429 | 7 | 7 | 4.66 | 123243 | 5.84958333 | CS |
156 | -0.68 | -9.71428571429 | 7 | 7 | 4.66 | 123243 | 5.84958333 | CS |
260 | -0.68 | -9.71428571429 | 7 | 7 | 4.66 | 123243 | 5.84958333 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約